Cureton Medical Services Ltd 13167236 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is the provision of medical services. Digita Accounts Production Advanced 6.30.9574.0 true true 13167236 2023-02-01 2024-01-31 13167236 2024-01-31 13167236 core:RetainedEarningsAccumulatedLosses 2024-01-31 13167236 core:ShareCapital 2024-01-31 13167236 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 13167236 core:Non-currentFinancialInstruments core:AfterOneYear 2024-01-31 13167236 bus:SmallEntities 2023-02-01 2024-01-31 13167236 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13167236 bus:FullAccounts 2023-02-01 2024-01-31 13167236 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13167236 bus:RegisteredOffice 2023-02-01 2024-01-31 13167236 bus:Director1 2023-02-01 2024-01-31 13167236 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13167236 countries:EnglandWales 2023-02-01 2024-01-31 13167236 2022-02-01 2023-01-31 13167236 2023-01-31 13167236 core:RetainedEarningsAccumulatedLosses 2023-01-31 13167236 core:ShareCapital 2023-01-31 13167236 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 13167236 core:Non-currentFinancialInstruments core:AfterOneYear 2023-01-31 iso4217:GBP xbrli:pure

Registration number: 13167236

Cureton Medical Services Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 January 2024

 

Cureton Medical Services Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Cureton Medical Services Ltd

(Registration number: 13167236)
Abridged Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Fixed assets

 

Investment property

225,000

-

Current assets

 

Debtors

6,146

34,185

Cash at bank and in hand

 

5,912

42,359

 

12,058

76,544

Creditors: Amounts falling due within one year

(10,805)

(13,349)

Net current assets

 

1,253

63,195

Total assets less current liabilities

 

226,253

63,195

Creditors: Amounts falling due after more than one year

(142,410)

-

Net assets

 

83,843

63,195

Capital and reserves

 

Called up share capital

1,000

1,000

Profit and loss account

82,843

62,195

Total equity

 

83,843

63,195

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 2 July 2024 and signed on its behalf by:
 

Dr Peter Cureton

Director

 

Cureton Medical Services Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU
Somerset

These financial statements were authorised for issue by the Board on 2 July 2024.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard FRS102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Cureton Medical Services Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).